Is the Cochlear (ASX:COH) share price a buy after a 14% decline after the HY25 result?
Jaz Harrison
February 15, 2025
The Cochlear Ltd (ASX:COH) share price fell 14% on Friday
Cochlear Ltd (ASX: COH) is one of the world’s leading medical businesses. Cochlear designs, manufactures and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant. Graeme Clark invented the first device in 1982, allowing first-user Graham Carrick to hear for the first time for 17 years. Some of the most recent modifications allow users to play sound from their phone directly into their implant.
The Cochlear Ltd (ASX:COH) share price fell 14% on Friday
John Addis is the founder of Intelligent Investor and author
Drew Meredith, CFP and Owen Rask dive into Emerging Markets
The Cochlear Ltd (ASX:COH) share price dropped 7% in response
The local market was buoyed by another strong day of
Here’s today’s The Match Out report from Market Matters’ James
The Cochlear Limited (ASX:COH) share price is up 4% after
The S&P/ASX200 (INDEXASX: XJO) down 0.6 per cent with the
Here’s today’s The Match Out report from Market Matters’ James
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
Here you go: A $50,000 per year passive income special report
Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.
Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.
Unsubscribe anytime. Read our Terms, Financial Services Guide, Privacy Policy. We’ll never sell your email address. Our company is Australian owned.